How do rules about drug advertising protect consumers from misleading claims?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

In the United States, rules regarding drug advertising are designed to protect consumers from misleading claims by ensuring that marketing practices are fair, accurate, and substantiated. The Federal Trade Commission (FTC) plays a central role in this oversight, enforcing the Federal Trade Commission Act to prevent deceptive trade practices.12

Key mechanisms for consumer protection include:

  • Requirement for Substantiation: Advertisers must have a reasonable basis for their claims before they are made. Even if a claim happens to be true, it is considered false advertising if the company lacked evidence, such as clinical tests, to support it at the time of publication.3
  • Focus on Deceptive Quality: The law prioritizes the potential effect on the consumer over the advertiser's intent. If an advertisement is deceptive in nature, it is actionable regardless of whether the company intended to mislead the public.3
  • Regulatory Enforcement: The FTC monitors compliance and can issue cease-and-desist orders, file civil suits, or require consent agreements to stop questionable behavior.12
  • Vigorous Health Oversight: The FTC is particularly stringent regarding health-related claims, ensuring that advertisements do not imply superior efficacy through omission or misleading comparisons.13